1. Home
  2. INBX vs DHIL Comparison

INBX vs DHIL Comparison

Compare INBX & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • DHIL
  • Stock Information
  • Founded
  • INBX 2010
  • DHIL 1990
  • Country
  • INBX United States
  • DHIL United States
  • Employees
  • INBX N/A
  • DHIL N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • DHIL Investment Managers
  • Sector
  • INBX Health Care
  • DHIL Finance
  • Exchange
  • INBX Nasdaq
  • DHIL Nasdaq
  • Market Cap
  • INBX 345.8M
  • DHIL 392.1M
  • IPO Year
  • INBX 2020
  • DHIL 1995
  • Fundamental
  • Price
  • INBX $26.54
  • DHIL $140.26
  • Analyst Decision
  • INBX Hold
  • DHIL
  • Analyst Count
  • INBX 2
  • DHIL 0
  • Target Price
  • INBX N/A
  • DHIL N/A
  • AVG Volume (30 Days)
  • INBX 112.9K
  • DHIL 25.5K
  • Earning Date
  • INBX 11-13-2025
  • DHIL 11-03-2025
  • Dividend Yield
  • INBX N/A
  • DHIL 4.24%
  • EPS Growth
  • INBX N/A
  • DHIL 21.42
  • EPS
  • INBX N/A
  • DHIL 17.58
  • Revenue
  • INBX $1,400,000.00
  • DHIL $151,281,009.00
  • Revenue This Year
  • INBX N/A
  • DHIL N/A
  • Revenue Next Year
  • INBX N/A
  • DHIL N/A
  • P/E Ratio
  • INBX N/A
  • DHIL $8.02
  • Revenue Growth
  • INBX N/A
  • DHIL 6.29
  • 52 Week Low
  • INBX $10.81
  • DHIL $122.32
  • 52 Week High
  • INBX $30.23
  • DHIL $173.25
  • Technical
  • Relative Strength Index (RSI)
  • INBX 52.65
  • DHIL 42.55
  • Support Level
  • INBX $27.51
  • DHIL $139.13
  • Resistance Level
  • INBX $28.86
  • DHIL $145.76
  • Average True Range (ATR)
  • INBX 1.38
  • DHIL 2.41
  • MACD
  • INBX -0.37
  • DHIL -0.30
  • Stochastic Oscillator
  • INBX 8.54
  • DHIL 11.35

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

Share on Social Networks: